Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Current Deferred Revenue: 2013-2017

Historic Current Deferred Revenue for Armata Pharmaceuticals (ARMP) over the last 4 years, with Sep 2017 value amounting to $20,000.

  • Armata Pharmaceuticals' Current Deferred Revenue rose 11.11% to $20,000 in Q3 2017 from the same period last year, while for Sep 2017 it was $20,000, marking a year-over-year increase of 11.11%. This contributed to the annual value of $245,000 for FY2015, which is 0.41% up from last year.
  • Armata Pharmaceuticals' Current Deferred Revenue amounted to $20,000 in Q3 2017, which was down 65.52% from $58,000 recorded in Q2 2017.
  • In the past 5 years, Armata Pharmaceuticals' Current Deferred Revenue registered a high of $350,000 during Q2 2015, and its lowest value of $18,000 during Q3 2016.
  • For the 3-year period, Armata Pharmaceuticals' Current Deferred Revenue averaged around $135,100, with its median value being $114,000 (2015).
  • Per our database at Business Quant, Armata Pharmaceuticals' Current Deferred Revenue slumped by 92.71% in 2016 and then spiked by 34.88% in 2017.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Current Deferred Revenue stood at $244,000 in 2013, then remained steady at $244,000 in 2014, then increased by 0.41% to $245,000 in 2015, then crashed by 92.71% to $18,000 in 2016, then climbed by 11.11% to $20,000 in 2017.
  • Its Current Deferred Revenue was $20,000 in Q3 2017, compared to $58,000 in Q2 2017 and $86,000 in Q1 2017.